The KDM6A/B inhibition affects viability of SMARCB1 deficient tumors through the disruption of autophagy and angiogenesis in pediatric cancer.

ID: 2656 Autores: Romero-Ferraro, Octavio (0); Vilarrubí , Andrea (1); Navajas, Pablo  (1); Morillas, Juan M (1); Díaz, Ana Cristina (1);...